Literature DB >> 6593726

Target polypeptide of a carcinogen is associated with normal mitosis and carcinogen-induced hyperplasias in adult hepatocytes.

R P Custer, S Sorof.   

Abstract

Normal rat liver cytosol was found previously to contain a 14,000-dalton polypeptide that is the principal target of the carcinogen N-2-fluorenylacetamide (2-acetyl-aminofluorene) early during hepatocarcinogenesis. By using antiserum that identifies the 14,000-dalton polypeptide in liver cytosol, an immunologically related 17,500-dalton polypeptide was shown to be present in isolated normal liver nuclei, tightly bound to chromatin. We report here that the 14,000-dalton polypeptide is associated with cell multiplication in normal adult hepatocytes. Of 150 hepatocytes in five stages of mitosis, all invariably displayed a greatly increased concentration of the 14,000-dalton polypeptide in cytoplasm, compared to hepatocytes in interphase, by immunostaining with peroxidase-antiperoxidase complex. In contrast, mitosis did not appear to affect the level of the 17,500-dalton polypeptide in nuclei. A small population of high-polyploid hepatocytes with large nuclei had elevated intensities of cytoplasmic immunostain that approached that in mitotic cells. The increased level of discernible 14,000-dalton polypeptide target of the carcinogen in cytoplasm is a marker of the rare mitotic hepatocytes in normal adult rat liver. Ingestion of the liver carcinogen N-2-fluorenylacetamide for 5 wk or an azocarcinogen, 3'-methyl-4-dimethylaminoazobenzene, for 4 wk brought about early foci of hyperplastic hepatocytes in which there was a great overload of detectable 14,000-dalton target polypeptide in their cytoplasm and a near absence of the 17,500-dalton polypeptide in most nuclei. In contrast, the cytoplasm and nuclei in surrounding morphologically nontransformed hepatocytes of livers of the carcinogen-fed rats immunostained to a much smaller degree than in normal adult hepatocytes. Removal of the azo-dye carcinogen for 4 wk resulted in the disappearance of most hyperplastic foci. A few foci did persist and had similar apparent abnormal levels of the two polypeptides. The high concentration of discernible 14,000-dalton target polypeptide in the cytoplasm of hepatocytes in the hyperplastic foci correlates with their known proliferation, whereas the low cytoplasmic level in the surrounding hepatocytes is consistent with the known inhibition of their mitosis by these carcinogens. The collected evidence appears to joint together a chemical carcinogen, a cytoplasmic principal target polypeptide, a chromatin-bound polypeptide, mitosis in normal adult hepatocytes, early and persistent hyperplastic foci caused by carcinogens, and the inhibition of mitosis by carcinogens in surrounding parenchyma in preneoplastic livers.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6593726      PMCID: PMC392006          DOI: 10.1073/pnas.81.21.6738

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  13 in total

1.  Changes in the composition of rat liver chromatin fractions during nitrosamine carcirogenesis.

Authors:  M Gronow; T Thackrah
Journal:  Eur J Cancer       Date:  1974-01       Impact factor: 9.162

2.  Regression and persistence of hyperplastic hepatic nodules induced by N-2-Fluorenylacetamide and their relationship to hepatocarcinogenesis.

Authors:  G W Teebor; F F Becker
Journal:  Cancer Res       Date:  1971-01       Impact factor: 12.701

3.  Early events during liver carcinogenesis involving two carcinogen:protein complexes.

Authors:  G R Blackburn; J P Andrews; R P Custer; S Sorof
Journal:  Cancer Res       Date:  1981-10       Impact factor: 12.701

Review 4.  The sequential analysis of cancer development.

Authors:  E Farber; R Cameron
Journal:  Adv Cancer Res       Date:  1980       Impact factor: 6.242

Review 5.  Oncogene expression in liver regeneration and hepatocarcinogenesis.

Authors:  N Fausto; P R Shank
Journal:  Hepatology       Date:  1983 Nov-Dec       Impact factor: 17.425

6.  Principal polypeptide target of carcinogen at the beginning of liver carcinogenesis by three carcinogens.

Authors:  G R Blackburn; S J Schnabel; J M Danley; R A Hogue-Angeletti; S Sorof
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

7.  Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis.

Authors:  D B Solt; A Medline; E Farber
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

8.  Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules.

Authors:  E C Miller; J A Miller
Journal:  Cancer       Date:  1981-05-15       Impact factor: 6.860

9.  An early event associated with liver carcinogenesis involving loss of a polypeptide that binds carcinogen.

Authors:  G R Blackburn; J P Andrews; K V Rao; S Sorof
Journal:  Cancer Res       Date:  1980-12       Impact factor: 12.701

Review 10.  Mechanisms of chemical carcinogenesis.

Authors:  E C Miller; J A Miller
Journal:  Cancer       Date:  1981-03-01       Impact factor: 6.860

View more
  11 in total

Review 1.  Liver fatty acid-binding protein and obesity.

Authors:  Barbara P Atshaves; Gregory G Martin; Heather A Hostetler; Avery L McIntosh; Ann B Kier; Friedhelm Schroeder
Journal:  J Nutr Biochem       Date:  2010-11       Impact factor: 6.048

Review 2.  Fatty acid-binding protein expression in the liver: its regulation and relationship to the zonation of fatty acid metabolism.

Authors:  N M Bass
Journal:  Mol Cell Biochem       Date:  1990 Oct 15-Nov 8       Impact factor: 3.396

3.  Specific growth stimulation by linoleic acid in hepatoma cell lines transfected with the target protein of a liver carcinogen.

Authors:  T Keler; C S Barker; S Sorof
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

4.  Brain lipid binding protein in axon-Schwann cell interactions and peripheral nerve tumorigenesis.

Authors:  Shyra J Miller; Hongzhen Li; Tilat A Rizvi; Yuan Huang; Gunnar Johansson; Jason Bowersock; Amer Sidani; John Vitullo; Kristine Vogel; Linda M Parysek; Jeffrey E DeClue; Nancy Ratner
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

5.  A new nucleosomal protein in normal liver related to the cytoplasmic polypeptide target of a carcinogen.

Authors:  J A Bassuk; S Sorof
Journal:  Mol Cell Biochem       Date:  1985-09       Impact factor: 3.396

6.  Liver fatty acid-binding protein: specific mediator of the mitogenesis induced by two classes of carcinogenic peroxisome proliferators.

Authors:  S H Khan; S Sorof
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

7.  Liver fatty acid binding protein is the mitosis-associated polypeptide target of a carcinogen in rat hepatocytes.

Authors:  J A Bassuk; P N Tsichlis; S Sorof
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

Review 8.  Modulation of mitogenesis by liver fatty acid binding protein.

Authors:  S Sorof
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

9.  Regulation of hepatic level of fatty-acid-binding protein by hormones and clofibric acid in the rat.

Authors:  S Nakagawa; Y Kawashima; A Hirose; H Kozuka
Journal:  Biochem J       Date:  1994-02-01       Impact factor: 3.857

10.  Candidates for tumor markers of cervical cancer discovered by proteomic analysis.

Authors:  Jae Yun Song; Hyo Sook Bae; Do Hyoung Koo; Jae Kwan Lee; Hak Hyun Jung; Kyu Wan Lee; Nak Woo Lee
Journal:  J Korean Med Sci       Date:  2012-12-07       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.